QA: Altimmune Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001326190_2017_Altimmune_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001326190, Altimmune Inc

  xvar xval
0 AssetsCurrent 222,269,826
1 IntangibleAssetsNetIncludingGoodwill 2,348,453
2 PropertyPlantAndEquipmentNet 120,944
3 remainder_Assets 0
4 LiabilitiesCurrent 204,837,543
5 LiabilitiesNoncurrent 442,589
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,808,430
9 ResearchAndDevelopmentExpense 5,443,779
10 remainder_Expenses 11,645,693
11 remainder_Revenues 0
12 remainder_NetIncome 209,406,286
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 224,739,223
1 Liabilities 205,280,132
2 Expenses 28,897,902
3 Revenues 0
4 StockholdersEquity 19,459,091
5 NetIncome 180,508,384
6 ComprehensiveNetIncome 180,508,384
7 BaseVar 334,161,772
8 EconomicCapitalRatiobeforeLimitedLiability 1.04
9 EconomicCapitalRatio 2.33

Edgar->Model Mapping

Feature Distribution

Change over Time